MLP AG (ETR:MLP) | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Home
Companies
MLP AG

BRIEF

published on 11/14/2025 at 10:19, 20 days 20 hours ago

MLP SE Maintains Core Strength Despite Challenges

Real Estate Development NuWays AG MLP SE EBIT Guidance Banking Sector
PRESS RELEASE

published on 11/14/2025 at 10:14, 20 days 20 hours ago

Original-Research: MLP SE (von NuWays AG): BUY
NuWays AG research update recommends BUY for MLP SE with a target price of EUR 12.50. Q3 review highlights healthy core business performance despite reduced EBIT guidance

Buy Recommendation NuWays AG Research Update MLP SE Q3 Review
BRIEF

published on 11/13/2025 at 07:37, 21 days 23 hours ago

MLP Group Reports New Revenue Records Amidst Strategic Growth

Financial Services Strategic Growth EBIT Forecast MLP Group Revenue Records
PRESS RELEASE

published on 11/13/2025 at 07:32, 21 days 23 hours ago

9M 2025: Successful consulting business – once again new record levels for revenue and key figures
MLP SE reports new record levels for revenue and key figures in 9M 2025, with total revenue reaching EUR 773 million and EBIT at EUR 61.1 million. Strategic growth plans include EBIT of EUR 140-155 million by 2028

Revenue Growth Plans MLP SE Record Levels 9M 2025
BRIEF

published on 11/07/2025 at 10:29, 27 days 20 hours ago

MLP Group Revises 2025 EBIT Forecast

Real Estate Wealth Management Business Strategy EBIT Forecast MLP Group
PRESS RELEASE

published on 11/07/2025 at 10:24, 27 days 20 hours ago

EQS-Adhoc: MLP SE: MLP Group adjusts its EBIT full year forecast for 2025 and intends focussing the business at Group company Deutschland.Immobilien
MLP Group adjusts EBIT forecast for 2025 to EUR 90-100 million and focuses on Deutschland.Immobilien business. Earnings in Q3 2025 exceeded previous year

EBIT Forecast 2025 MLP Group Deutschland.Immobilien Business Focusing
BRIEF

published on 08/15/2025 at 09:05, 3 months 20 days ago

NuWays AG Maintains Buy Rating on MLP SE Despite Mixed Q2 Results

Buy Recommendation MLP SE Q2 Results EBIT Guidance Insurance Growth
PRESS RELEASE

published on 08/15/2025 at 09:00, 3 months 20 days ago

Original-Research: MLP SE (von NuWays AG): BUY
NuWays AG releases an update research report on MLP SE, confirming a 'BUY' recommendation with a target price of EUR 13.00. Q2 results show mixed sales performance but in line with estimates, maintaining FY'25 EBIT guidance of €100-110m

NuWays AG MLP SE Q2 Results Research Report FY'25 EBIT Guidance
BRIEF

published on 08/14/2025 at 07:51, 3 months 21 days ago

MLP SE Sets New Revenue Record in H1 2025

Growth Strategy Revenue EBIT MLP SE 2025 Forecast
PRESS RELEASE

published on 08/14/2025 at 07:46, 3 months 21 days ago

MLP SE: 'H1 2025: New record set for revenue, EBIT forecast for full year confirmed'
MLP SE reports record revenue in H1 2025, confirms EBIT forecast for full year. Revenue growth in all fields; assets under management reach EUR 63.9 billion

Revenue Growth MLP SE EBIT Forecast Assets Under Management

1 2 ... 8

Accesswire

Published on 12/05/2025 at 02:35, 4 hours 33 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 4 hours 38 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 6 hours 8 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 3 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 8 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 3 hours 37 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 17 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 42 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 53 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 57 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 13 hours 8 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 23 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 23 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE